A carregar...

Interaction of WBP2 with ERα increases doxorubicin resistance of breast cancer cells by modulating MDR1 transcription

BACKGROUND: Surgery combined with new adjuvant chemotherapy is the primary treatment for early stage invasive and advanced stage breast cancer. Growing evidence indicates that patients with ERα-positive breast cancer show poor response to chemotherapeutics. However, ERα-mediated drug-resistant mecha...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Chen, Shuai, Wang, Han, Li, Zhi, You, Jun, Wu, Qiu-Wan, Zhao, Can, Tzeng, Chi-Meng, Zhang, Zhi-Ming
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6048156/
https://ncbi.nlm.nih.gov/pubmed/29937544
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0119-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!